| Literature DB >> 30426006 |
Yiyi Feng1, Yuchen Fang1, Yiqin Wang1, Yiming Hao1.
Abstract
Acupoint therapy is one of the therapeutic means in Traditional Chinese Medicine (TCM) concerning acupoints and meridians, including manual acupuncture, electroacupuncture, moxibustion, external application, acupoint injection, and catgut embedding. In the treatment of diabetes and its common chronic complications, acupoint therapy has proved to have specific curative effect and notable advantages. Single or combined with western medicine, it has superior efficacy and less side effects than western medicine alone. Studying its mechanism can provide experimental basis for clinical treatment. Relevant researches in the recent 5 years mainly focused on the mechanism of electroacupuncture, point injection, catgut embedding, etc. in the treatment of diabetes and common diabetic complications such as neuropathy, nephropathy, and hepatopathy. The possible theories involve the regulation of nerve conduction, signal pathways, hormone level, protein expression, oxidative stress level, structure restoration, etc. The most studied acupoints are Zusanli (ST36), Shenshu (BL23), Sanyinjiao (SP6), Yishu (EX-B3), and Zhongwan (CV12). However, most of the studies have been based on diabetes model rats rather than clinical trials. Moreover, the mechanism of acupoint therapy treating other chronic complications like diabetic retinopathy and that of other effective methods like pressing ear with beans, auricular points plaster therapy, and external application remain unclear. Therefore, this aspect still awaits further research.Entities:
Mesh:
Substances:
Year: 2018 PMID: 30426006 PMCID: PMC6217896 DOI: 10.1155/2018/3128378
Source DB: PubMed Journal: Biomed Res Int Impact factor: 3.411
The function and effect of acupoint therapy on DM and its common chronic complications.
|
|
|
|
|
|
|
|---|---|---|---|---|---|
| Diabetes mellitus | T2DM rats | Yishu (EX-B3) | Electroacupuncture | 1. Innervate the pancreas by neural segment | 1. Protect the islets |
| T2DM rats | Zusanli (ST36), Shenshu (BL23) | Electroacupuncture | High-level expression of gene GLUT2 and GCK | Reduce insulin resistance | |
| T2DM rats | Quchi (LI11), Hegu (LI4), Zusanli (ST36), Xuehai (SP10), Fenglong (ST40), Yinlingquan (SP9), Diji (SP8), Sanyinjiao (SP6), Taichong (LR3) | Manual acupuncture | High-level expression of gene IRS-1, IRS-2, and GLUT4 | ||
| T2DM rats | Zusanli (ST36), Quchi (LI11) | Electroacupuncture | Low-level expression of PI3K-85p | Reduce insulin resistance | |
| Otsuka Long-Evans Tokushima Fatty (OLETF) rats | Zusanli (ST36), Shenshu (BL23), Neiguan (PC6), Sanyinjiao (SP6) | Electroacupuncture | 1. High-level of IRS-1, IRS-2, Akt2, aPKC | Reduce insulin resistance | |
| T2DM rats | Zusanli (ST36), Shenshu (BL23), Neiguan (PC6), Sanyinjiao (SP6) | Electroacupuncture | High-level expression of IRS-1, PI3K, Akt2, and eNOS | 1. Reduce insulin resistance | |
|
| |||||
| Diabetic peripheral neuropathy (include diabetic gastroparesis) | DPN rats | Zusanli (ST36), Shenshu (BL23) | 1. Electroacupuncture | High-level expression of nerve growth factor and its receptor TrkA | 1. Promote the regeneration of nerves |
| DPN rats | Pishu (BL20), Shenshu (BL23), Zusanli (ST36) | 1. Catgut implantation at acupoint | 1. High-level expression of nerve growth factor | ||
| Chinese DPN patients | Zusanli (ST36) | 1. Acupoint injection of salvia injections | 1. Low-level expression of high-sensitivity C-reactive protein | Protect the structure of neurons | |
| Chinese DPN patients | Zusanli (ST36), Zhongwan (CV12), Mingmen (DU4) | 1. Electroacupuncture | 1. Low-level expression of high-sensitivity C-reactive protein | ||
| DGP rats | Zusanli (ST36), Zhongwan (CV12) | Electroacupuncture | High-level expression of stem cell factors and neuronal nitric oxide synthase | Restore the ultrastructure and pacing function of interstitial cells of Cajal in the gastric antrum | |
| Chinese DGP patients | Zhongwan (CV12), Xiawan (RN10), Qihai (BL24), Guanyuan (BL26), Tianshu (ST25), Daheng (SP15), Huaroumen (ST24), and Wailing (ST26) | 1. Abdominal acupuncture | Enhance the secretion of motilin and gastrin | Regulate gastrointestinal functions and motility | |
| Chinese DGP patients | Zusanli (ST36) | Acupoint injection of mecobalamin | |||
| DGP rats | Zusanli (ST36), Liangmen (ST21), and Sanyinjiao (SP6) | Electroacupuncture | 1. Growth in endothelial nitric oxide synthase, insulin and its receptor in the gastric antrum | 1. Promote the restoration of Cajal interstitial cells | |
|
| |||||
| Diabetic cardiac autonomic neuropathy | DM rats | Feishu (BL13), Xinshu (BL15), Yishu (EX-B3), Pishu (BL20), Neiguan (PC6), Quchi (LI11), Zusanli (ST36), Sanyinjiao (SP6) | Electroacupuncture | 1. Low-level expression of nerve growth factor | 1. Prohibit abnormal proliferation of neurons |
|
| |||||
| Diabetic foot | Chinese level 0 diabetic foot patients | Jiexi (ST41) | Acupoint injection of Vitamin B1 | 1. High content of 6-Keto-PGF1 | 1. Supply the nutrition of neurons |
|
| |||||
| Diabetic anterior horn injury of spinal cord | DM rats | Zusanli (ST36), Yishu (EX-B3) | Electroacupuncture | 1. High-level expression of gene Bcl-2 | Prevent the apoptosis of neurons |
|
| |||||
| Diabetic myopathy | DM rats | Yanglingquan (GB34) and Zusanli (ST36) | Electroacupuncture | 1. Up-regulates IGF-1 signaling pathway | 1. Promote the muscle regeneration |
|
| |||||
| Diabetic nephropathy | Chinese DN patients | Zusanli (ST36), Sanyinjiao (SP6), Fenglong (ST40), Yinlingquan (SP9), and Zhongshu (DU7) | Acupoint injection of Shuxuening (extract from gingko leaf that contains flavanoids, phenols, alkaloids, etc.) | Low-level expression of vascular endothelial growth factor | 1. Ameliorate the expansion of extracellular matrix and mesangial matrix of kidney |
| DN rats | Shenshu (BL23), Huiyang (BL35), Guanyuan (BL26) | 1. Catgut implantation at acupoint | Low content of transforming growth factor- | 1. Ameliorate the glucose metabolism and renal hemodynamics | |
| Chinese DN patients | Zhongwan (CV12), Quchi (LI11), Hegu (LI4), Xuehai (SP10), Zusanli (ST36), Yinlingquan (SP9) | Manual Acupuncture | 1. Regulate gene IFNG, T cell receptor, hypoxia inducible factor-1, JAK-STAT signaling pathway, TGF- | 1. Improve glomerular filtration and reduce urinary albumin excretion rate | |
|
| |||||
| Diabetic hepatopathy | DM rats | Yishu (EX-B3) | Electroacupuncture | 1. High-level expression of gene and protein of glucagon-like peptide-1 receptor | Protect liver cells |
Figure 1The appearance frequency of most mentioned acupoints in the articles of recent five years.